Switzerland: The new Swiss regulatory framework
The Swiss law governing the marketing authorisation for medicinal products has been completely renewed at the end of 2018.
Continue ReadingExport growth increasingly depends on pharmaceuticals
Swiss exports hit a record CHF210 billion ($211 billion) last year and the pharmaceutical sector was one of the big drivers.
Continue ReadingRoche profits fall due to strong Swiss franc. New analysis.
The world’s largest maker of cancer drugs raked in a net profit of nine billion Swiss francs ($8.9 billion), falling short of expectations.
Continue Reading